Fuso Pharmaceutical Industries,Ltd. [4538.T]
TOKYO, May 12 (Pulse News Wire) – Fuso Pharmaceutical Industries,Ltd. (4538.T) reported non-consolidated results for fiscal year 2026 ending March.
Revenue was ¥62.3 billion (+2.9% YoY). operating profit was ¥2,639 million (-36.1%). net profit was ¥2,011 million.
Total assets stood at ¥90.3 billion with an equity ratio of 38.8%. The company declared an annual dividend of ¥45 per share. The full-year forecast for the current fiscal year is revenue of ¥63.2 billion (+1.4%).
Financial results — FY2026/3 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥62,307M | +2.9% |
| Operating profit | ¥2,639M | -36.1% |
| Net profit | ¥2,011M | n/a |
Next period forecast
Revenue
¥63,200M
+1.4%Op. profit
¥2,000M
-24.2%Net profit
¥1,300M
-35.4%Source: TDNet filing · Figures in millions of yen
🟢 Confidence: High AI-translated content.